SST2-based model for evaluating prognosis of malignant tumor patient and application of sST2-based model
A technology for malignant tumors and tumor patients, applied in the field of biomedical testing, to achieve the effect of timely and effective communication between doctors and patients
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0043] The patient visited the doctor on June 1, 2020, aged 68, male. 2020-5-27 Gastric adenocarcinoma was diagnosed by gastroscopy. Pathology showed that the tumor invaded the muscularis propria. PET-CT showed perigastric lymph node metastasis and multiple liver metastases. Has not received any anti-tumor therapy. Laboratory tests were performed after admission, sST2 45ng / mL, LDH 150U / L, CRP10mg / L.
[0044] In this case, according to the 8th edition of the AJCC staging of gastric cancer, tumor invasion into the muscularis propria was judged as T2, perigastric lymph node metastasis was judged as N+, multiple liver metastases were judged as M1, comprehensive assessment: stage IV. Therefore, the data index of its risk factor is 1 point.
[0045] In this case, the onset age of the patient was 68 years old, that is, ≥65 years old, and the data index of the risk factor was 1 point.
[0046] In this case, the sST2 45ng / mL was detected before the patient received any anti-tumor th...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com